FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/03/031929 [Registered on: 11/03/2021] Trial Registered Prospectively
Last Modified On: 05/03/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Dentistry 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   comparative evaluation of bone graft with a blood product and bone graft alone in treatment of bone defects created by gum diseases. 
Scientific Title of Study   “Comparative Clinical and Radiographic Evaluation of the Efficacy of Autologous Injectable Platelet-Rich Fibrin (iPRF) with Demineralized freeze dried bone allograft (DFDBA) and Normal Saline with Demineralized freeze dried bone allograft (DFDBA) used in the Treatment Of Intrabony Defects in Chronic Periodontitis Patients –A Randomized Clinical Trial” 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR BHALCHANDRA THORAT 
Designation  First year PG in periodontics 
Affiliation  Nair hospital and dental college 
Address  201, Department of periodontics, second floor, Nair hospital dental college opposite to Maratha Mandir Mumbai central- 400008

Mumbai
MAHARASHTRA
400012
India 
Phone  7249590890  
Fax    
Email  bmbt5691@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR MALA DIXIT BABURAJ  
Designation  Professor and H.O.D of the department 
Affiliation  Nair hospital dental college 
Address  201,Department of periodontics Nair hospital dental college opposite to Maratha Mandir Mumbai central- 400008

Mumbai
MAHARASHTRA
400008
India 
Phone  9223340938  
Fax    
Email  maladixit25@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR MALA DIXIT BABURAJ  
Designation  Professor and H.O.D of the department 
Affiliation  Nair hospital and dental college 
Address  201,Department of periodontics Nair hospital dental college opposite to Maratha Mandir Mumbai central- 400008

Mumbai
MAHARASHTRA
400008
India 
Phone  9223340938  
Fax    
Email  maladixit25@gmail.com  
 
Source of Monetary or Material Support  
Nair Hospital Dental College Mumbai central 400008 
 
Primary Sponsor  
Name  DR BHALCHANDRA THORAT 
Address  201,Department of periodontics Nair hospital and dental college opposite to maratha mandir, mumbai central- 400008 
Type of Sponsor  Other [self sponsored] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR BHALCHANDRA THORAT  Nair hospital dental college  Department of periodontics,201
Mumbai
MAHARASHTRA 
7249590890

bmbt5691@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee NHDC  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  , (1) ICD-10 Condition: K05||Gingivitis and periodontal diseases, (2) ICD-10 Condition: R688||Other general symptoms and signs,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Demineralized freeze dried bone allograft with injectable platelet rich fibrin   After centrifugation, the blood is separated into a yellow orange upper phase (i-PRF) and a red lower phase. The yellow part will be collected using a syringe and added to a cup that contains the bone graft material. The collected i-PRF maintains its fluid phase for up to 10 to 15 minutes after centrifugation. The i-PRF consolidated bone graft will placed in to the intraosseous defect.Patients will be evaluated clinically at1,3,6 months postoperatively 
Intervention  Demineralized freeze dried bone allograft with normal saline   Open flap debridement, followed by placement of Normal saline with demineralized freeze-dried bone allograft (DFDBA) in the infrabony defect.Patients will be evaluated clinically at 1,3,6 months. 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Age group between 20-60years
Diagnosis with chronic periodontitis
Patients in good systemic health with no contraindication to periodontal surgery
Patients having Intrabony defects with pocket depths of 5mm or more,intrabony defect of 3mm with radiographic evidence of vertical / angular bone loss in the affected sites.
Involved teeth to be vital and with no endodontic lesion. 
 
ExclusionCriteria 
Details  One — wall osseous defects.
Patients suffering from any systemic diseases or with compromised immune system.
Patients who had received any type of periodontal therapy for the past 6 months
Patients taking any immuno-suppressive drugs like corticosteroids.
Patients with a known history of allergy to doxycycline or Chlorhexidine or any other medicine are used in the study.
Patients showing unacceptable oral hygiene compliance during /after the phase I therapy.
Patients taking any drug known to cause gingival enlargement.
Pregnant and/or lactating mothers.
Patients who were smokers or had tobacco in any other form.
Endodontically treated teeth.
Patient on anticoagulant therapy
Patient with bleeding disorders. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Plaque index(SILNESS & LOE 1964)
Gingival index(LOE & SILNESS 1963)
Probing pocket depth(PPD)
Clinical attachment Level(CAL) 
baseline 1 month 3months and 6 months postoperatively. 
 
Secondary Outcome  
Outcome  TimePoints 
Radiographic bone fill will be evaluated using intraoral periapical radiographs of the surgical site.  Radiographs will be taken immediatly post surgery and at six month post surgery 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   19/03/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="8"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Regeneration of lost structures has become the primary therapeutic goal in periodontics. The objectives of periodontal regenerative therapy are to reconstitute the bone, cementum and periodontal ligament on a previously diseased root surface. Numerous therapeutic modalities for restoring periodontal osseous defects have been investigated. Many of these procedures include the use of bone grafts and bone replacement materials. For the last few decades, demineralized freeze-dried bone allograft (DFDBA) has been used alone and in combination with other treatment modalities for periodontal regeneration. The presence of bone morphogenetic proteins contained within DFDBA aids in
mesenchymal cell migration, attachment, and osteogenesis. 

To evaluate and compare clinically and radiographically the effect of Autologus injectable platelet–rich fibrin (iPRF) with demineralized freeze-dried bone allograft(DFDBA) v/s Normal saline with demineralized freeze-dried bone allograft(DFDBA)in the treatment of infrabony periodontal defect and its effecton clinical parameter like Plaque index,  Gingival index, Probing pocket depth and Clinical attachment level.
 
Close